Hudson Bay Capital Management’s Viridian Therapeutics VRDN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.67M Buy
+119,562
New +$1.67M 0.01% 582
2024
Q1
Sell
-35,176
Closed -$766K 785
2023
Q4
$766K Buy
+35,176
New +$766K ﹤0.01% 463